Medscape November 15, 2024
Miriam E. Tucker

TOPLINE:

Since 1990, the largest increase in diabetes prevalence has occurred in low-income and middle-income countries, whereas improvements in treatment have been greatest in high-income and industrialized nations and some emerging economies, especially in Latin America. These trends have widened the global gap in diabetes prevalence and treatment, with an increasing share of people with diabetes, especially with untreated diabetes, living in low-income and middle-income countries.

METHODOLOGY:

  • In what is believed to be the first global analysis of trends in both diabetes prevalence and treatment coverage over all countries, the investigators analyzed and pooled 1108 population-representative studies with measures of glycemic biomarkers and data on diabetes treatment for a total 141 million adult participants.

TAKEAWAY:

  • In 2022,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider, Survey / Study, Trends
Smartwatches reveal insights into psychiatric illnesses and genetic links
Digital therapeutics: Exploring the road to commercialization across international markets
B2C2B models gaining traction in HealthTech
Are popular weight loss drugs putting your patients at risk?
How are employers going to pay for cell and gene therapies?

Share This Article